We are live on ! Find out more
SIOX

Sio Gene Therapies Inc. Common Stock
SIOX

Delisted

SIOX was delisted on the 22nd of March, 2023.

Back to rankings

95 hedge funds and large institutions have $1.43B invested in Sio Gene Therapies Inc. Common Stock in 2016 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 28 increasing their positions, 23 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

364% more call options, than puts

Call options by funds: $14.4M | Put options by funds: $3.1M

343% more capital invested

Capital invested by funds: $323M → $1.43B (+$1.11B)

117% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 12

22% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 23

17% more funds holding

Funds holding: 81 → 95 (+14)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

Holders
95
Holders Change
+14
Holders Change %
+17.28%
% of All Funds
2.53%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
26
Increased
28
Reduced
23
Closed
12
Calls
$14.4M
Puts
$3.1M
Net Calls
+$11.3M
Net Calls Change
+$11M

Top Buyers

Rank Fund Capital Flow
1
QF
QVT Financial
New York
+$1.13B
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$15.6M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$9.68M
4
Millennium Management
Millennium Management
New York
+$9.43M
5
DM
Deerfield Management
New York
+$8.52M

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$8.59M
2
PA
Perceptive Advisors
New York
-$6.23M
3
JP Morgan Chase
JP Morgan Chase
New York
-$5.91M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$4.25M
5
JHIU
Janus Henderson Investors US
Colorado
-$3.47M
Name Holding Trade Value Shares
Change 		Change in
Stake
VM
26
VHCP Management
New York
$2.58M – – –
AFG
27
American Financial Group
Ohio
$2.41M – – –
JGC
28
J. Goldman & Co
New York
$1.99M +$2.13M +17,750 New
AA
29
ALPS Advisors
Colorado
$1.77M -$193K -1,609 -9%
KCM
30
Kingdon Capital Management
New York
$1.74M +$1.86M +15,524 New
Vanguard Group
31
Vanguard Group
Pennsylvania
$1.72M +$48.7K +406 +3%
BG
32
BlackRock Group
United Kingdom
$1.57M -$541K -4,508 -24%
BIM
33
BlackRock Investment Management
Delaware
$1.42M -$63.5K -529 -4%
NC
34
Nexthera Capital
New York
$1.4M +$1.5M +12,500 New
SM
35
Sabby Management
Florida
$1.3M -$1.45M -12,111 -51%
Bank of New York Mellon
36
Bank of New York Mellon
New York
$1.09M +$85.7K +714 +8%
HCM
37
Highbridge Capital Management
New York
$1.06M +$1.13M +9,439 New
DAM
38
Deltec Asset Management
New York
$1.05M +$968K +8,062 +614%
ACM
39
Atika Capital Management
New York
$1.04M +$1.11M +9,250 New
Renaissance Technologies
40
Renaissance Technologies
New York
$977K +$1.05M +8,725 New
Ameriprise
41
Ameriprise
Minnesota
$850K -$7.56K -63 -0.8%
AIM
42
Assured Investment Management
New York
$756K +$810K +6,748 New
California State Teachers Retirement System (CalSTRS)
43
California State Teachers Retirement System (CalSTRS)
California
$723K +$6K +50 +0.8%
NFA
44
Nationwide Fund Advisors
Ohio
$676K -$18.8K -157 -3%
AllianceBernstein
45
AllianceBernstein
Tennessee
$654K – – –
Swiss National Bank
46
Swiss National Bank
Switzerland
$638K -$57K -475 -8%
SO
47
STRS Ohio
Ohio
$635K -$51K -425 -7%
Goldman Sachs
48
Goldman Sachs
New York
$623K +$467K +3,891 +233%
Morgan Stanley
49
Morgan Stanley
New York
$616K +$535K +4,459 +427%
Deutsche Bank
50
Deutsche Bank
Germany
$596K +$501K +4,174 +362%
1
2
3 4 5

SIOX Hedge Fund Activity: Q3 2016 in Review

95 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Sio Gene Therapies Inc. Common Stock (SIOX) for Q3 2016, worth a combined $1.43B — up 343% from $323M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new SIOX positions and 12 closed out — a net gain of 14 holders — while 28 added to existing stakes and 23 trimmed.

The largest buyer was QVT Financial, opening a new position worth an estimated $1.13B. The largest seller was Citadel Advisors, exiting entirely with an estimated $8.59M sold.

  • 95 institutional investors held Sio Gene Therapies Inc. Common Stock (SIOX) as of Q3 2016, up from 81 in Q2 2016.
  • Funds reported $1.43B of Sio Gene Therapies Inc. Common Stock stock for Q3 2016, up 343% quarter-over-quarter.
  • 26 funds opened new Sio Gene Therapies Inc. Common Stock positions in Q3 2016 and 12 closed out, a net change of +14 holders.
  • The largest Sio Gene Therapies Inc. Common Stock buyer in Q3 2016 was QVT Financial, an estimated $1.13B added.
  • The largest Sio Gene Therapies Inc. Common Stock seller in Q3 2016 was Citadel Advisors, an estimated $8.59M sold.

Based on aggregated 13F filings for Q3 2016.